Healy and Collins strike a deal

Article Abstract:

Collins has agreed to lead the human genome research center in Bethesda, MD. Healy sees this as a major coup for the NIH. Collins has helped make major gains in applying gene therapy to medicine. A new institute, The National Institute for Human Genetics is expected to be formed.

Human Genome Project

---

Genome project plans described

Article Abstract:

Molecular geneticist Francis Collins will head the National Center for Human Genome Research (NCHGR) and plans to establish the first intramural NCHGR lab at the National Institutes of Health. Major challenges facing Collins in his new position and endeavor are described.

---

Healy approves an unproven treatment

Article Abstract:

Bernadine Healy approved the use of a gene therapy not yet sanctioned by NIH for a brain cancer patient. The therapy will use a genetically altered form of the patient's own cancer cells. NIH states that the approval is a unique situation that will not be repeated.

Care and treatment, Usage, Laws, regulations and rules, Science and technology policy, Gene therapy, United States. National Institutes of Health, Brain cancer, Healy, Bernadine P.

Similar abstracts:

• Abstracts: Neptunium and plutonium solubilities in a Yucca mountain groundwater. Microbes show promise for bioremediating plutonium
• Abstracts: Agencies spar over vaccine trial. MicroGeneSys withdraws from trial. Lobbying for an AIDS trial
• Abstracts: Sounding out science. Oil on water. Sound science: researchers still sparring over effects of Exxon Valdez
• Abstracts: HHS: Gallo guilty of misconduct. Stubborn HIV reservoirs vulnerable to new treatments. Eradicating HIV from a patient: not just a dream?
• Abstracts: 'Strategic research' wins the day. NSF wins, NIH loses in Clinton's 1994 budget. SSC deathwatch starts again

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.